等待开盘 01-16 09:30:00 美东时间
-0.005
0.00%
今日重点评级关注:HC Wainwright & Co.:维持奥麦罗制药"买入"评级,目标价从20美元升至40美元;HC Wainwright & Co.:维持Cullinan Therapeutics"买入"评级,目标价从26美元升至27美元
01-09 20:22
UBS analyst Jay Sole maintains Tapestry (NYSE:TPR) with a Neutral and raises the price target from $105 to $123.
01-09 02:06
2025 was a rollercoaster for Benzinga chat room participants, with mixed opinions on various stocks; 2026 may see escalation of China/Taiwan issue.
01-01 05:06
转自:贝壳财经 站在“十五五”新程待启的关键时点,如何看待2026年的经济形势?2026年经济工作怎么干?新京报贝壳财经推出《看2026:十五五·启新程》专题报...
2025-12-30 13:52
经营14年,下沉的COACH撤出广州太古汇。 COACH广州太古汇门店。时代财经摄 2011年,美国轻奢品牌COACH首次进穗,入驻广州太古汇。如今,C...
2025-12-25 16:26
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
2025-12-17 10:46
今日重点评级关注:杰富瑞:维持ImmunityBio Inc Ordinary Shares"买入"评级,目标价从8美元升至9美元;B. Riley证券:维持WAVE Life Sciences"买入"评级,目标价从19美元升至37美元
2025-12-15 15:30
Jefferies analyst Ashley Helgans maintains Tapestry (NYSE:TPR) with a Buy and raises the price target from $135 to $142.
2025-12-13 02:42
Guggenheim analyst Simeon Siegel initiates coverage on Tapestry (NYSE:TPR) with a Neutral rating.
2025-12-10 19:30